Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.
Identifieur interne : 001897 ( Pmc/Curation ); précédent : 001896; suivant : 001898Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.
Auteurs : J L Keulemans ; A J Reuser ; M A Kroos ; R. Willemsen ; M M Hermans ; A M Van Den Ouweland ; J G De Jong ; R A Wevers ; W O Renier ; D. Schindler ; M J Coll ; A. Chabas ; H. Sakuraba ; Y. Suzuki ; O P Van DiggelenSource :
- Journal of Medical Genetics [ 0022-2593 ] ; 1996.
Abstract
Up to now eight patients with alpha-NAGA deficiency have been described. This includes the newly identified patient reported here who died unexpectedly aged 1 1/2 years of hypoxia during convulsions; necropsy was not performed. Three patients have been genotyped previously and here we report the mutations in the other five patients, including two new mutations (S160C and E193X). The newly identified patient is consanguineous with the first patients reported with alpha-NAGA deficiency and neuroaxonal dystrophy and they all had the alpha-NAGA genotype E325K/E325K. Clinical heterogeneity among patients with alpha-NAGA deficiency is extreme. Two affected sibs, homozygotes for E325K, are severely affected and have the signs and symptoms of infantile neuroaxonal dystrophy, but prominent vacuolisation is lacking. The mildly affected patients (two families, three patients) at the opposite end of the clinical spectrum have clear vacuolisation and angiokeratoma but no overt neurological manifestations. Two of them are homozygous for the stop mutation E193X, leading to complete loss of alpha-NAGA protein. These observations are difficult to reconcile with a simple genotype-phenotype correlation and we suggest that factors or genes other than alpha-NAGA contribute to the clinical heterogeneity of the eight patients with alpha-NAGA deficiency. At the metabolic level, the patients with alpha-NAGA deficiency are similar. The major abnormal urinary oligosaccharides are sialylglycopeptides of the O linked type. Our enzymatic studies indicated that these compounds are not the primary lysosomal storage products.
Url:
PubMed: 8782044
PubMed Central: 1050630
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001898
Links to Exploration step
PMC:1050630Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.</title>
<author><name sortKey="Keulemans, J L" sort="Keulemans, J L" uniqKey="Keulemans J" first="J L" last="Keulemans">J L Keulemans</name>
</author>
<author><name sortKey="Reuser, A J" sort="Reuser, A J" uniqKey="Reuser A" first="A J" last="Reuser">A J Reuser</name>
</author>
<author><name sortKey="Kroos, M A" sort="Kroos, M A" uniqKey="Kroos M" first="M A" last="Kroos">M A Kroos</name>
</author>
<author><name sortKey="Willemsen, R" sort="Willemsen, R" uniqKey="Willemsen R" first="R" last="Willemsen">R. Willemsen</name>
</author>
<author><name sortKey="Hermans, M M" sort="Hermans, M M" uniqKey="Hermans M" first="M M" last="Hermans">M M Hermans</name>
</author>
<author><name sortKey="Van Den Ouweland, A M" sort="Van Den Ouweland, A M" uniqKey="Van Den Ouweland A" first="A M" last="Van Den Ouweland">A M Van Den Ouweland</name>
</author>
<author><name sortKey="De Jong, J G" sort="De Jong, J G" uniqKey="De Jong J" first="J G" last="De Jong">J G De Jong</name>
</author>
<author><name sortKey="Wevers, R A" sort="Wevers, R A" uniqKey="Wevers R" first="R A" last="Wevers">R A Wevers</name>
</author>
<author><name sortKey="Renier, W O" sort="Renier, W O" uniqKey="Renier W" first="W O" last="Renier">W O Renier</name>
</author>
<author><name sortKey="Schindler, D" sort="Schindler, D" uniqKey="Schindler D" first="D" last="Schindler">D. Schindler</name>
</author>
<author><name sortKey="Coll, M J" sort="Coll, M J" uniqKey="Coll M" first="M J" last="Coll">M J Coll</name>
</author>
<author><name sortKey="Chabas, A" sort="Chabas, A" uniqKey="Chabas A" first="A" last="Chabas">A. Chabas</name>
</author>
<author><name sortKey="Sakuraba, H" sort="Sakuraba, H" uniqKey="Sakuraba H" first="H" last="Sakuraba">H. Sakuraba</name>
</author>
<author><name sortKey="Suzuki, Y" sort="Suzuki, Y" uniqKey="Suzuki Y" first="Y" last="Suzuki">Y. Suzuki</name>
</author>
<author><name sortKey="Van Diggelen, O P" sort="Van Diggelen, O P" uniqKey="Van Diggelen O" first="O P" last="Van Diggelen">O P Van Diggelen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">8782044</idno>
<idno type="pmc">1050630</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1050630</idno>
<idno type="RBID">PMC:1050630</idno>
<date when="1996">1996</date>
<idno type="wicri:Area/Pmc/Corpus">001898</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001898</idno>
<idno type="wicri:Area/Pmc/Curation">001897</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001897</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.</title>
<author><name sortKey="Keulemans, J L" sort="Keulemans, J L" uniqKey="Keulemans J" first="J L" last="Keulemans">J L Keulemans</name>
</author>
<author><name sortKey="Reuser, A J" sort="Reuser, A J" uniqKey="Reuser A" first="A J" last="Reuser">A J Reuser</name>
</author>
<author><name sortKey="Kroos, M A" sort="Kroos, M A" uniqKey="Kroos M" first="M A" last="Kroos">M A Kroos</name>
</author>
<author><name sortKey="Willemsen, R" sort="Willemsen, R" uniqKey="Willemsen R" first="R" last="Willemsen">R. Willemsen</name>
</author>
<author><name sortKey="Hermans, M M" sort="Hermans, M M" uniqKey="Hermans M" first="M M" last="Hermans">M M Hermans</name>
</author>
<author><name sortKey="Van Den Ouweland, A M" sort="Van Den Ouweland, A M" uniqKey="Van Den Ouweland A" first="A M" last="Van Den Ouweland">A M Van Den Ouweland</name>
</author>
<author><name sortKey="De Jong, J G" sort="De Jong, J G" uniqKey="De Jong J" first="J G" last="De Jong">J G De Jong</name>
</author>
<author><name sortKey="Wevers, R A" sort="Wevers, R A" uniqKey="Wevers R" first="R A" last="Wevers">R A Wevers</name>
</author>
<author><name sortKey="Renier, W O" sort="Renier, W O" uniqKey="Renier W" first="W O" last="Renier">W O Renier</name>
</author>
<author><name sortKey="Schindler, D" sort="Schindler, D" uniqKey="Schindler D" first="D" last="Schindler">D. Schindler</name>
</author>
<author><name sortKey="Coll, M J" sort="Coll, M J" uniqKey="Coll M" first="M J" last="Coll">M J Coll</name>
</author>
<author><name sortKey="Chabas, A" sort="Chabas, A" uniqKey="Chabas A" first="A" last="Chabas">A. Chabas</name>
</author>
<author><name sortKey="Sakuraba, H" sort="Sakuraba, H" uniqKey="Sakuraba H" first="H" last="Sakuraba">H. Sakuraba</name>
</author>
<author><name sortKey="Suzuki, Y" sort="Suzuki, Y" uniqKey="Suzuki Y" first="Y" last="Suzuki">Y. Suzuki</name>
</author>
<author><name sortKey="Van Diggelen, O P" sort="Van Diggelen, O P" uniqKey="Van Diggelen O" first="O P" last="Van Diggelen">O P Van Diggelen</name>
</author>
</analytic>
<series><title level="j">Journal of Medical Genetics</title>
<idno type="ISSN">0022-2593</idno>
<idno type="eISSN">1468-6244</idno>
<imprint><date when="1996">1996</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Up to now eight patients with alpha-NAGA deficiency have been described. This includes the newly identified patient reported here who died unexpectedly aged 1 1/2 years of hypoxia during convulsions; necropsy was not performed. Three patients have been genotyped previously and here we report the mutations in the other five patients, including two new mutations (S160C and E193X). The newly identified patient is consanguineous with the first patients reported with alpha-NAGA deficiency and neuroaxonal dystrophy and they all had the alpha-NAGA genotype E325K/E325K. Clinical heterogeneity among patients with alpha-NAGA deficiency is extreme. Two affected sibs, homozygotes for E325K, are severely affected and have the signs and symptoms of infantile neuroaxonal dystrophy, but prominent vacuolisation is lacking. The mildly affected patients (two families, three patients) at the opposite end of the clinical spectrum have clear vacuolisation and angiokeratoma but no overt neurological manifestations. Two of them are homozygous for the stop mutation E193X, leading to complete loss of alpha-NAGA protein. These observations are difficult to reconcile with a simple genotype-phenotype correlation and we suggest that factors or genes other than alpha-NAGA contribute to the clinical heterogeneity of the eight patients with alpha-NAGA deficiency. At the metabolic level, the patients with alpha-NAGA deficiency are similar. The major abnormal urinary oligosaccharides are sialylglycopeptides of the O linked type. Our enzymatic studies indicated that these compounds are not the primary lysosomal storage products.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><graphic xlink:href="jmedgene00260-0020-a" xlink:role="460"></graphic>
</fig>
<fig id="F2"><graphic xlink:href="jmedgene00260-0020-b" xlink:role="460"></graphic>
</fig>
<fig id="F3"><graphic xlink:href="jmedgene00260-0021-a" xlink:role="461"></graphic>
</fig>
<fig id="F4"><graphic xlink:href="jmedgene00260-0021-b" xlink:role="461"></graphic>
</fig>
<fig id="F5"><graphic xlink:href="jmedgene00260-0022-a" xlink:role="462"></graphic>
</fig>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Med Genet</journal-id>
<journal-title>Journal of Medical Genetics</journal-title>
<issn pub-type="ppub">0022-2593</issn>
<issn pub-type="epub">1468-6244</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">8782044</article-id>
<article-id pub-id-type="pmc">1050630</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype.</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Keulemans</surname>
<given-names>J L</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Reuser</surname>
<given-names>A J</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Kroos</surname>
<given-names>M A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Willemsen</surname>
<given-names>R</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Hermans</surname>
<given-names>M M</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>van den Ouweland</surname>
<given-names>A M</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>de Jong</surname>
<given-names>J G</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Wevers</surname>
<given-names>R A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Renier</surname>
<given-names>W O</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Schindler</surname>
<given-names>D</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Coll</surname>
<given-names>M J</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Chabas</surname>
<given-names>A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Sakuraba</surname>
<given-names>H</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Suzuki</surname>
<given-names>Y</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>van Diggelen</surname>
<given-names>O P</given-names>
</name>
</contrib>
</contrib-group>
<aff>Department of Clinical Genetics, Erasmus University, Rotterdam, The Netherlands.</aff>
<pub-date pub-type="ppub"><month>6</month>
<year>1996</year>
</pub-date>
<volume>33</volume>
<issue>6</issue>
<fpage>458</fpage>
<lpage>464</lpage>
<abstract><p>Up to now eight patients with alpha-NAGA deficiency have been described. This includes the newly identified patient reported here who died unexpectedly aged 1 1/2 years of hypoxia during convulsions; necropsy was not performed. Three patients have been genotyped previously and here we report the mutations in the other five patients, including two new mutations (S160C and E193X). The newly identified patient is consanguineous with the first patients reported with alpha-NAGA deficiency and neuroaxonal dystrophy and they all had the alpha-NAGA genotype E325K/E325K. Clinical heterogeneity among patients with alpha-NAGA deficiency is extreme. Two affected sibs, homozygotes for E325K, are severely affected and have the signs and symptoms of infantile neuroaxonal dystrophy, but prominent vacuolisation is lacking. The mildly affected patients (two families, three patients) at the opposite end of the clinical spectrum have clear vacuolisation and angiokeratoma but no overt neurological manifestations. Two of them are homozygous for the stop mutation E193X, leading to complete loss of alpha-NAGA protein. These observations are difficult to reconcile with a simple genotype-phenotype correlation and we suggest that factors or genes other than alpha-NAGA contribute to the clinical heterogeneity of the eight patients with alpha-NAGA deficiency. At the metabolic level, the patients with alpha-NAGA deficiency are similar. The major abnormal urinary oligosaccharides are sialylglycopeptides of the O linked type. Our enzymatic studies indicated that these compounds are not the primary lysosomal storage products.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><graphic xlink:href="jmedgene00260-0020-a" xlink:role="460"></graphic>
</fig>
<fig id="F2"><graphic xlink:href="jmedgene00260-0020-b" xlink:role="460"></graphic>
</fig>
<fig id="F3"><graphic xlink:href="jmedgene00260-0021-a" xlink:role="461"></graphic>
</fig>
<fig id="F4"><graphic xlink:href="jmedgene00260-0021-b" xlink:role="461"></graphic>
</fig>
<fig id="F5"><graphic xlink:href="jmedgene00260-0022-a" xlink:role="462"></graphic>
</fig>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001897 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 001897 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Pmc |étape= Curation |type= RBID |clé= PMC:1050630 |texte= Human alpha-N-acetylgalactosaminidase (alpha-NAGA) deficiency: new mutations and the paradox between genotype and phenotype. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:8782044" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |